AZGP1 antibody (N-Term)

Catalog No. ABIN452775

The Rabbit Polyclonal anti-AZGP1 antibody (ABIN452775) specifically detects AZGP1 in WB and EIA. The antibody is reactive with Human samples.

Quick Overview for AZGP1 antibody (N-Term) (ABIN452775)

Target: AZGP1 (alpha-2-Glycoprotein 1, Zinc-Binding (AZGP1))

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This AZGP1 antibody is un-conjugated

Application: Western Blotting (WB), Enzyme Immunoassay (EIA)

Product Details anti-AZGP1 Antibody

Binding Specificity: N-Term

Specificity: This antibody detects AZGP1 at N-term.

Cross-Reactivity (Details): Species reactivity (tested):Human

Purification: Prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS

Immunogen: KLH conjugated synthetic peptide selected from the N-terminal region of human AZGP1

Application Details

Application Notes: Western blot: 1: 50 - 1: 100. ELISA: 1: 1,000.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 0.25 mg/mL

Buffer: PBS with 0.09 % (W/V) sodium azide

Preservative: Sodium azide

Precaution of Use: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handling Advice: Avoid repeated freezing and thawing.

Storage: 4 °C/-20 °C

Storage Comment: Store the antibody at 2 - 8 °C up to one month or (in aliquots) at -20 °C for longer.

Target Details for AZGP1

Target: AZGP1 (alpha-2-Glycoprotein 1, Zinc-Binding (AZGP1))

Alternative Name: AZGP1

Background: AZGP1 stimulates lipid degradation in adipocytes and causes the extensive fat losses associated with some advanced cancers. It may bind polyunsaturated fatty acids.Synonyms: ZAG, ZNGP1, Zinc-alpha-2-glycoprotein

Molecular Weight: 33872 Da

Gene ID: 563

NCBI Accession: NP_001176

UniProt: P25311

Pathways: Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process